UN envoy slams anti-Russian sanctions imposed over North KoreaRussian Politics & Diplomacy August 23, 21:29
Criminal case over Ukraine's map without Crimea and Donbass opened in KievWorld August 23, 21:17
Netanyahu says every encounter with Putin benefits Israel’s securityWorld August 23, 19:15
Netanyahu determined to prevent Iran from strengthening positions in SyriaWorld August 23, 18:21
Russia's military might on display at Army-2017 forumMilitary & Defense August 23, 18:20
Russian defense minister examines weapons seized from terrorists in SyriaMilitary & Defense August 23, 18:12
Grand Russian art exhibition to be held in Vatican in 2018Society & Culture August 23, 17:47
Argentinian footballer Emiliano Rigoni signs contract with Russia’s Zenit FCSport August 23, 17:36
German chancellor suggests exerting diplomatic pressure on North KoreaWorld August 23, 17:01
MOSCOW, October 5. /TASS/. Organizers of the French Open tennis tournament do not rule out that Russian tennis star Maria Sharapova will be handed a wild card to participate in the Grand Slam event in France next year, Roland Garros press service told TASS on Wednesday.
"The list of wildcards is decided 15 days before the tournament; we have time to think about it," the press service announced to TASS.
Sharapova has been serving a two-year suspension for the violation of anti-doping regulations since January 26. However, the Swiss-based Court of Arbitration for Sport (CAS) ruled on Tuesday to reduce Sharapova’s suspension term from 24 to 15 months.
The Russian player is now eligible to officially return back to tennis courts starting April 26 next year. The nearest Grand Slam tournament, which is the 2017 French Open, is scheduled for May 22-June 11 and the Russian tennis star will not have time to earn enough tournament points to join the tennis competition in France. Therefore the wildcard is her only chance to play at the French Grand Slam event.
Alexei Selivanenko, the vice president of the Russian Tennis Federation (RTF), told TASS that Sharapova was likely to receive a wildcard for the French Open.
"Sharapova will be resuming the tournament with zero rating," Selivanenko said in an interview with TASS. "It is obvious that before the beginning of the tournament she will be unable to gain enough points to earn the berth."
"However, the organizers of the tournament are most likely to grant a wildcard to such tennis player (as Sharapova)," Selivanenko added.
In early March, Sharapova was first to announce that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was officially announced on June 8 by the International Tennis Federation (ITF) Tribunal over anti-doping violations.
Due to the imposed ban Sharapova, the silver Olympic medalist of the 2012 Games in London, had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
Mildronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without a doctor’s prescription.